Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Over half of the adult women with acne in the study had higher than normal levels of male hormones, especially DHEA.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

South Asian women with PCOS present with different symptoms compared to White women, influenced by ethnicity, obesity, and age.

Intermittent low-dose finasteride works as well as daily use for treating excessive hair growth in women.

Exercise improves insulin sensitivity and hormone regulation in PCOS rats.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Daughters of women with PCOS generally experience normal puberty but may have more body hair and different body fat distribution.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Polycystic Ovary Syndrome can cause hair loss and skin issues, and early treatment is important for preventing complications.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

Low-dose finasteride reduces excessive hair growth in teenage girls safely and affordably.

AR gene not major factor in female hair loss; different from male hair loss.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.

High-intensity interval training improves certain hormone levels and lipid profiles in women with PCOS.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

Higher hs-CRP levels in Indian adolescent women with PCOS are more related to BMI than PCOS itself.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Rosiglitazone may be better than metformin for insulin resistance in PCOS, but more research is needed on certain biomarkers.